National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 22502 [2019-10235]
Download as PDF
<![CDATA[
22502
Federal Register / Vol. 84, No. 96 / Friday, May 17, 2019 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued
Type of respondent
Cohort 2—Youth Aged
11 to 18.
Totals .......................
1 There
Cohort 2—Youth Baseline Questionnaire.
Cohort 2—Youth 1st,
2nd, 3rd Followup
Questionnaire.
.........................................
Number of
responses per
respondent
Total annual
responses
Average burden
per response
Total hours
2,667
1
2,667
0.75 (45 minutes) ...
2,000
6,270
1
6,270
0.75 (45 minutes) ..
4,703
........................
........................
........................
................................
16,525
are no capital costs or operating and maintenance costs associated with this collection of information.
To accommodate the additional data
collection for media tracking, FDA
requests approval to increase the
number of burden hours under the
existing control number. The previous
number of approved screener responses
for media tracking was 60,000 and the
associated burden was 1,800 hours. The
previous burden for the media tracking
questionnaires was 6,000 and the
associated burden was 3,000 hours. We
are requesting an additional 20,000
screener responses and 2,000
questionnaire completions, which adds
600 burden hours and 1,000 burden
hours respectively. Deducting the
responses and burden for the completed
evaluation components associated with
Cohort 1 (general population screening
(13,413 responses, 2,281 hours), parent
interviews (3,342 responses, 569 hours),
youth questionnaires (8,954 responses,
6,144 hours)) and for the rural
smokeless evaluation (2,610 responses,
1,794 hours) results in a decrease of
6,319 annual responses and 9,187 hours.
Dated: May 14, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–10320 Filed 5–16–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended
Notice of Meeting
jbell on DSK3GLQ082PROD with NOTICES
Number of
respondents
Activity
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Council of Research Advocates,
May 20, 2019, 9:30 a.m. to 4:00 p.m.,
National Institutes of Health, Building
40, Room 1201/1203, 40 Convent Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
April 11, 2019, 84 FR 14662.
This meeting notice is amended to
change the meeting start time from 9:00
a.m. to 9:30 a.m. on May 20, 2019 at the
National Institutes of Health, Building
VerDate Sep<11>2014
20:15 May 16, 2019
Jkt 247001
40, Room 1201/1203, 40 Convent Drive,
Bethesda, MD 20892. This meeting is
open to the public.
Dated: May 13, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–10217 Filed 5–16–19; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health, Two Democracy
Boulevard, Suite 920, 6707 Democracy Blvd.,
Bethesda, MD 20892, 301–451–4794,
dennis.hlasta@nih.gov.
Dated: May 13, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–10235 Filed 5–16–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Alcohol Abuse and
Alcoholism.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Resources for
Technology Dissemination (U24) Review
Meeting (2019/08).
Date: June 27, 2019.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging, and Bioengineering,
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism.
Date: June 6, 2019.
Time: 1:30 p.m. to 2:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive, Room
1206, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Abraham P. Bautista,
Ph.D., Executive Secretary, National
Advisory Council, Director, Office of
Extramural Activities, National Institute On
Alcohol Abuse And Alcoholism, 6700 B
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
E:\FR\FM\17MYN1.SGM
17MYN1
]]>Agencies
[Federal Register Volume 84, Number 96 (Friday, May 17, 2019)]
[Notices]
[Page 22502]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10235]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Institute
of Biomedical Imaging and Bioengineering Special Emphasis Panel.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; Resources for Technology
Dissemination (U24) Review Meeting (2019/08).
Date: June 27, 2019.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, Suite
920, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging, and Bioengineering,
National Institutes of Health, Two Democracy Boulevard, Suite 920,
6707 Democracy Blvd., Bethesda, MD 20892, 301-451-4794,
[email protected].
Dated: May 13, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-10235 Filed 5-16-19; 8:45 am]
BILLING CODE 4140-01-P
